JANET WEIR: Open Payments
NPI 1699041418 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 8 payments from 6 companies in 2025. Trend: 2023 $429 · 2024 $698 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $199 |
| Abbott Laboratories | 2 | $193 |
| Madrigal Pharmaceuticals | 1 | $145 |
| Alnylam Pharmaceuticals Inc. | 1 | $144 |
| ABBVIE INC. | 1 | $122 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: AUSTEDO XR, REZDIFFRA, ONPATTRO, ALINITY, QULIPTA, INFINITY, MYFEMBREE.
Industry payments across CA — which companies pay providers there.
